Matinas BioPharma Holdings MTNB
NYSE MTNB
$2.86 +0.33 (+12.85%)
As of: Sep 29, 2026 · 3:59 PM EDT

Matinas BioPharma Holdings (MTNB) Current Assets (2013 - 2026)

Updated

Matinas BioPharma Holdings (MTNB) recorded Current Assets of $1.14 million in Q2 2026, down 84.3% from $7.27 million a year earlier and down 59.4% from the prior quarter.

Analysis

Matinas BioPharma Holdings (MTNB) Current Assets (2013 - 2026) Analysis & Trends

At the end of FY2025, Matinas BioPharma Holdings reported Current Assets of $4.08 million, down 49.2% from FY2024.

  • Annual Current Assets has declined for five straight years, with a five-year compound annual growth rate of -41.9% (FY2020 to FY2025).
  • Across earlier years, Current Assets came in at $8.03 million in FY2024 (-48.4%), $15.54 million in FY2023 (-55.0%), $34.53 million in FY2022 (-32.3%) and $50.99 million in FY2021 (-17.2%).
  • The Q2 2026 figure is the lowest quarterly Current Assets since Q2 2016.
  • On a year-over-year basis, Current Assets has declined for 22 consecutive quarters, with an average decline of 52.1% over the last eight quarters.
  • The year-over-year decline in Current Assets has ranged between 13.4% (Q3 2021) and 84.3% (Q2 2026) over the last five years.
  • Per Business Quant, the preceding three quarters came in at $2.82 million (Q1 2026), $4.08 million (Q4 2025) and $5.65 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Matinas BioPharma Holdings 16.27 Mn 3.68 Mn - 1.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.14 Mn
Mar 31, 2026 2.82 Mn
Dec 31, 2025 4.08 Mn
Sep 30, 2025 5.65 Mn
Jun 30, 2025 7.27 Mn
Mar 31, 2025 7.55 Mn
Dec 31, 2024 8.03 Mn
Sep 30, 2024 11.74 Mn
Jun 30, 2024 15.29 Mn
Mar 31, 2024 10.29 Mn
Dec 31, 2023 15.54 Mn
Sep 30, 2023 19.99 Mn
Jun 30, 2023 24.00 Mn
Mar 31, 2023 28.21 Mn
Dec 31, 2022 34.53 Mn
Sep 30, 2022 37.10 Mn
Jun 30, 2022 41.92 Mn
Mar 31, 2022 45.12 Mn
Dec 31, 2021 50.99 Mn
Sep 30, 2021 56.48 Mn
API Access

Matinas BioPharma Holdings Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=MTNB&period=max&api_key=YOUR_API_KEY